L-AP4 inhibits high voltage-activated Ca2+ currents in pyramidal cortical neurones

NeuroReport

Volumn 7, Issue 2, 1996, Pages 421-424

  Stefani, Alessandro ^a,b   Spadoni, Francesca ^a   Bernardi, Giorgio ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

HVA Ca2+ currents; L AP4 receptors; Metabotropic glutamate receptors; Rat

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; CALCIUM CHANNEL; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; INTRACELLULAR RECORDING; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

AMINO ACIDS, DICARBOXYLIC; AMINOBUTYRIC ACIDS; ANIMALS; BARIUM; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; CYCLOLEUCINE; EXCITATORY AMINO ACID AGONISTS; ION CHANNEL GATING; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEUROTOXINS; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 0029967471     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199601310-00011     Document Type: Article

References (25)

1. Nakanishi S. Science 13, 597-603 (1992).
2. Schoepp DD and Conn PJ. Trends Pharm Sci 14, 13-20 (1993).
3. Pin JP and Duvoisin R. Neuropharmacology 34, 1-26 (1995).
4. Stefani A, Pisani A, Mercuri NB et al. Mol Neurobiol, submitted, 1995.
5. Tanabe Y, Nomura A, Masu A et al. J Neurosci 13, 1372-1378 (1993).
6. Koerner JF and Cotman CW. Brain Res 216, 192-198 (1981).
7. Cotman CW, Flatman JA, Ganong H et al. J Physiol 318, 403-415 (1986).
8. Trombley PQ and Westbrook GL. J Neurosci 12, 2043-2050 (1992).
9. Rainnie DG and Shinnick-Gallagher P. J Physiol 139, 87-91 (1992).
10. Wan H and Cahusac PMB. J Physiol 483, 155-156P (1995).
11. Wan H. and Cahusac PMB. Neuropharmacology 34, 1053-1062 (1995).
12. Burke JP and Hablitz JJ. J Neurosci 14, 5120-5130 (1994).
13. Burke JP and Hablitz JJ. J Neurophysiol (1995).
14. Calabresi P, Pisani A, Mercuri NB et al. Eur J Neurosci 5, 1370-1377 (1993).
15. Lovinger D and McCool BA. J Neurophysiol 73, 1076-1081 (1995).
16. Vasquez E, Budd DC, Herrero I et al. Neuropharmacology 34, 919-927 (1995).
17. Bruno V, Battaglia G, Copani A et al. Eur J Pharmacol 256, 109-112 (1994).
18. Copani A, Bruno V, Battaglia G et al. Mol Pharmacol 47, 890-897 (1995).
19. Stefani A, Pisani A, Mercuri NB et al. J Neurosci 14, 6734-6743 (1994).
20. Stefani A, Pisani A, De Murtas M et al. Epilepsia 336, 997-1002 (1995).
21. Jane DE, Jones PL St.J, Pook PC-K et al. Br J Pharmacol 112, 809-816 (1994).
22. Kemp M, Roberts P, Pook P et al. Eur J Pharmacol 266, 187-192 (1994).
23. Knopfel T, Lukic S, Leonard T et al. Neuropharmacology 34, 1099-1103 (1995).
24. Kinzie JM, Saugstad JA, Westbrook GL et al. Neuroscience 69, 167-176 (1995).
25. Siesj YBK and Bengtsson. J Cerebr Blood Flow Metab 9, 127-140 (1989).